Inventor · disambiguated record
Marc Ferrer
Also filed as: FERRER MARC
11 granted patents·13 pending applications·25 citations·filing 2002–2025
83Inventor score
Files withUS HEALTH8THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES3UNIV JOHNS HOPKINS3THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC2ESPESETH AMY S1
Top patents by PatentIndex Score
24 records- 0185US9550742B211-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonistsTHE US SECRETARY DEPT OF HEALTH AND HUMAN·Filed 2014·Granted Jan 24, 2017·21 cites·22 claims
- 0283US11253511B2Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)UNIV JOHNS HOPKINS·Filed 2017·Granted Feb 22, 2022·2 cites·4 claims
- 0379US11471460B2Autophagy modulators for use in treating cancerUS HEALTH·Filed 2020·Granted Oct 18, 2022·1 cites·8 claims
- 0477US2024316056A1Formulations and methods for the prevention and treatment of tumor metastasis and tumorigenesisUS HEALTH·Filed 2024·Application pending·0 cites
- 0576US2025340521A1C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2025·Application pending·0 cites
- 0673US12435047B2c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2023·Granted Oct 7, 2025·0 cites·19 claims
- 0771US12145922B2Selective D3 dopamine receptor agonists and methods of their useUS HEALTH·Filed 2023·Granted Nov 19, 2024·0 cites·21 claims
- 0870US12208093B2Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)UNIV JOHNS HOPKINS·Filed 2022·Granted Jan 28, 2025·0 cites·4 claims
- 0965US11241436B2Autophagy inducers for treatment of CNS conditionsUNIV NORTHWESTERN·Filed 2018·Granted Feb 8, 2022·1 cites·9 claims
- 1059US2021186972A1Formulations and methods for the prevention and treatment of tumor metastasis and tumorigenesisTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2019·Application pending·0 cites
- 1159US2025134907A1Fused diazepines as agonists of the insulin-like 3 (insl3) peptide receptor rxfp2 and methods of use thereofUS HEALTH·Filed 2023·Application pending·0 cites
- 1258US11649218B2C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2019·Granted May 16, 2023·0 cites·18 claims
- 1357US11766423B22,6-dimethoxy-4-(5-phenyl-4-thiophene-2-yl-1H-imidazol-2-yl)-phenol (DPTIP) a small molecule inhibitor of neutral sphingomyelinase 2 (nSMase-2) for the treatment of neurodegenerative and oncologic diseasesUNIV JOHNS HOPKINS·Filed 2019·Granted Sep 26, 2023·0 cites·2 claims
- 1455US11634404B2Selective D3 dopamine receptor agonists and methods of their useUS HEALTH·Filed 2017·Granted Apr 25, 2023·0 cites·16 claims
- 1554US2024141291A1Functional brain region-specific neural spheroids and methods of useTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2022·Application pending·0 cites
- 1654US2024336604A1D3 dopamine receptor-selective negative allosteric modulatorsUS HEALTH·Filed 2022·Application pending·0 cites
- 1752US2022315548A1Small molecule agonists of mucolipin 1 and uses thereofUNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 1845US2006270841A1Assays to monitor amyloid precursor protein processingESPESETH AMY S·Filed 2003·Application pending·0 cites
- 1944US2014155420A1Inhibitors of eya2ZHAO RUI·Filed 2012·Application pending·0 cites
- 2042US2017001988A1Piperidine and piperazine derivatives and their use in treating viral infections and cancerUS HEALTH·Filed 2014·Application pending·0 cites
- 2141US2021040074A1Positive allosteric modulators of dopamine 1 receptor and method of use thereofSIBLEY DAVID R·Filed 2019·Application pending·0 cites
- 2234US2005164311A1Biological assay detection methodFiled 2002·Application pending·0 cites
- 2333US2020165257A1Inhibitors of phosphoinositide 3-kinase and histone deacetylase for treatment of cancerTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2018·Application pending·0 cites
- 2432US10202367B2Heterocyclic compounds and methods of use thereofUS HEALTH·Filed 2015·Granted Feb 12, 2019·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →